Ukrainian Pharma: challenges and opportunities Pharmaceutical Industry Review, special issue, December 2022
We will work on emerging markets for these categories. Our priorities are enlargement of our opportunities, new technologies and development of Ukrainian pharma. In August we conducted a research*** with experts from Gradus Research company which confirm our assumption about necessity to extend product portfolio in the segment of mental health. 57% of Ukrainians informed that during last 6 months they had certain traumatic event concerning themselves or members of their family. However, only 13% asked for professional help. The situation requires active education of the population since timely professional assistance help
to reduce risks of chronic disease or its rise to higher level. We work in this direction as well as in the field of education for medical workers and have created information platform**** for doctors and patients. Considering geography of our interests, export extension is among our priorities. It’s necessary for our country since it guarantees currency inflow. We have ambitious plans to enter Australian market this year. Next year we intend to enter African markets, and then – till 2024 – to establish our presence in a new 25 countries. We are interested in the following regions: Europe, Africa, Middle East and Asia. In April, already during large scale war,
***The research by Gradus Research ordered by pharmaceutical company Darnitsa includes 1000 interviews of men and women aged 18-60 who live in the cities with population of 50 K inhabitants and more (19020 August, 2022). ****The platform is purely informational and is not intended for self diagnosis and self treatment. If having symptoms, please, visit the doctor.
we received GMP certificate from Australian regulator which opens Australian market for our medicines. By the way, Darnitsa’s business corresponds to international requirements to compliance. We have introduced ‘Code of business behavior and ethics’, ‘Policies on conflict of interests management’, ‘Code of business behavior of Darnitsa’s partners’. Thus we are completely prepared to requirements of international partners. Our company also actively provides humanitarian aid. During 10 months of 2022 we have donated over 1,9 M packages of medicines to the Ministry of Health, medical organizations and volunteers. Almost 120 organizations received medicines from Darnitsa for a total amount of UAH 173 M. The company also transported to Ukraine 10 thousand packages of hemostatic medicine Celox, and donated it to hospitals free of charge.
42
BACK TO CONTENTS
www.promoboz.com
www.promoboz.com |
www.cphem.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
